The offering

Sectra OneScreen is a simple first step to identify patients in the risk group for osteoporosis, who need further investigation and potential treatment. With a single, standard X-ray image of the hand it is possible to measure women’s bone health (Bone Mineral Density, BMD). The image is sent to our online service Sectra OneScreen. With the result and other known risk factors, you can easily identify individuals with increased risk of future fractures. The service is proven to be effective in monitoring the progress of osteoporosis.

The service is especially convenient in the context of mammography examinations and in the workflow at distal radius fractures.

How to use Sectra OneScreen

Using Sectra online service is very simple. Sectra OneScreen does all the work, all you need to do is to refer the patient to a hand X-ray. Sectra will assist with any set-up needed to send images via the Internet to our service (this is a one time set-up). The analysis is automated and quality reviewed by a certified operator before the result is sent electronically to the physician.

Combined mammography and osteoporosis assessment

With Sectra OneScreen you can easily conduct osteoporosis screening at the same time as the mammography examination - without disturbing the regular workflow. The hand x-ray is taken at the same time as the breast images, using the same radiology equipment - adding about 30 seconds to the overall examination time.

The technology

Sectra OneScreen uses the patented DXR-technology. It calculates bone mineral density (BMD) based on a single radiology image and is highly correlated to other methods of measure. Based on the World Health Organization standards, the BMD value is evaluated in relation to a reference group to diagnose osteoporosis.

Features and benefits

• OneScreen has the highest precision in market and can calculate bone mineral density (BMD) based on a single radiology image at any digital X-ray modality.
• There is no capital investment, cost is per analysis.
• With Sectra OneScreen you can easily combine the mammography examination with an osteoporosis assessment.
• The DXR-BMD estimation highly correlates to DXA-BMD.
• The OneScreen is CE labeled and has FDA approval in North America as a medical device.
• The DXR-technology is thoroughly evaluated clinically and well published by researchers worldwide. See clinical references.
• Each analysis is quality reviewed by a certified Sectra OneScreen operator before the result is sent electronically to the physician.